| Original language | English |
|---|---|
| Pages (from-to) | 56-57 |
| Number of pages | 2 |
| Journal | Amyloid |
| Volume | 24 |
| DOIs | |
| Publication status | Published - Mar 16 2017 |
ASJC Scopus subject areas
- Internal Medicine
Cite this
Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis. / Milani, Paolo; Schönland, Stefan; Palladini, Giovanni; Kimmich, Christoph; Basset, Marco; Russo, Francesca; Foli, Andrea; Perlini, Stefano; Bochtler, Tilmann; Ho, Anthony D.; Merlini, Giampaolo; Hegenbart, Ute.
In: Amyloid, Vol. 24, 16.03.2017, p. 56-57.Research output: Contribution to journal › Letter
}
TY - JOUR
T1 - Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis
AU - Milani, Paolo
AU - Schönland, Stefan
AU - Palladini, Giovanni
AU - Kimmich, Christoph
AU - Basset, Marco
AU - Russo, Francesca
AU - Foli, Andrea
AU - Perlini, Stefano
AU - Bochtler, Tilmann
AU - Ho, Anthony D.
AU - Merlini, Giampaolo
AU - Hegenbart, Ute
PY - 2017/3/16
Y1 - 2017/3/16
UR - http://www.scopus.com/inward/record.url?scp=85018756617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018756617&partnerID=8YFLogxK
U2 - 10.1080/13506129.2017.1292240
DO - 10.1080/13506129.2017.1292240
M3 - Letter
AN - SCOPUS:85018756617
VL - 24
SP - 56
EP - 57
JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
SN - 1350-6129
ER -